Litcius/Paper detail

T-Cells and Interferon Gamma Are Necessary for Survival Following Crimean-Congo Hemorrhagic Fever Virus Infection in Mice

David W. Hawman, Kimberly Meade‐White, Shanna Leventhal, Aaron Carmody, Elaine Haddock, Kim J. Hasenkrug, Heinz Feldmann

2021Microorganisms27 citationsDOIOpen Access PDF

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a severe tick-borne febrile illness with wide geographic distribution. In humans, the disease follows infection by the Crimean-Congo hemorrhagic fever virus (CCHFV) and begins as flu-like symptoms that can rapidly progress to hemorrhaging and death. Case fatality rates can be as high as 30%. An important gap in our understanding of CCHF are the host immune responses necessary to control the infection. A better understanding of these responses is needed to direct therapeutic strategies to limit the often-severe morbidity and mortality seen in humans. In this report, we have utilized a mouse model in which mice develop severe disease but ultimately recover. T-cells were robustly activated, differentiated to produce antiviral cytokines, and were critical for survival following CCHFV infection. We further identified a key role for interferon gamma (IFNγ) in survival following CCHFV infection. These results significantly improve our understanding of the host adaptive immune response to severe CCHFV infection.

Topics & Concepts

Crimean–Congo hemorrhagic feverImmunologyImmune systemCase fatality rateDiseaseVirologyInterferonVirusInterferon gammaMortality rateMedicineTickBiologyInternal medicineEpidemiologyViral Infections and VectorsMosquito-borne diseases and controlVector-Borne Animal Diseases